• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Evan Snyder elected to Association of American Physicians

Bioengineer by Bioengineer
April 4, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Sanford Burnham Prebys Medical Discovery Institute (SBP)

La Jolla, Calif., April 4, 2018 – Evan Y. Snyder, M.D., Ph.D., professor and founding director, Center for Stem Cells & Regenerative Medicine at Sanford Burnham Prebys Medical Discovery Institute (SBP) and professor at the University of California San Diego, has been elected to membership in the Association of American Physicians (AAP). AAP is a prestigious national society of physician-scientists who are elected based on their important scientific contributions that have ultimately impacted human health. Snyder will be inducted at the AAP annual meeting on April 21, 2018 in Chicago, Illinois.

"Evan is highly deserving of this honor," says Kristiina Vuori, M.D., Ph.D., president of SBP. "His pioneering research on the properties of stem cells has led to applications in a broad range of neurologic conditions, many in clinical trials today."

Snyder studies the basic and translational biology of stem cells (particularly neural) with the goal of understanding normal and aberrant development, tissue homeostasis and plasticity, inter-cellular communication, oncogenesis, and recovery of function. His lab uses stem cells to model disease pathogenesis and pathophysiology (for pathway mapping, therapeutic target identification, and drug discovery). He is a practicing clinician, a leader in regional ethics programs, and engaged in graduate and medical school education. He served two terms as Chairman of the FDA's Cellular, Tissue, and Gene Therapy Advisory Committee.

Snyder earned his M.D. and Ph.D. (in neuroscience) from the University of Pennsylvania and received training in Philosophy, Psychology, and Linguistics at Oxford University. He began his career as a physician-scientist at Harvard Medical School and Boston Children's Hospital where, in addition to running a lab and multidisciplinary research program, he remained clinically active in pediatrics, pediatric neurology, and newborn intensive care. In 2003, after 23 years at Harvard, he was recruited to SBP.

###

About SBP

Sanford Burnham Prebys Medical Discovery Institute (SBP) is an independent nonprofit medical research organization that conducts world-class, collaborative, biological research and translates its discoveries for the benefit of patients. SBP focuses its research on cancer, immunity, neurodegeneration, metabolic disorders and rare children's diseases. The Institute invests in talent, technology and partnerships to accelerate the translation of laboratory discoveries that will have the greatest impact on patients. Recognized for its world-class NCI-designated Cancer Center and the Conrad Prebys Center for Chemical Genomics, SBP employs about 1,000 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.

Media Contact

Susan Gammon
[email protected]
858-795-5012
@sbpdiscovery

http://www.sbpdiscovery.org/

Share12Tweet8Share2ShareShareShare2

Related Posts

Modular eFAST Phantom Advances AI Ultrasound Triage

October 9, 2025

Parabrachial Hub Governs Persistent Pain States

October 9, 2025

Family Resilience in Children with Cancer: A Study

October 9, 2025

Self-Collected HPV Tests Match Clinician Samples for Cervical Cancer

October 9, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1149 shares
    Share 459 Tweet 287
  • New Study Reveals the Science Behind Exercise and Weight Loss

    101 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    96 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    80 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

“Molecular Bodyguard” Enables Infections to Persist

Modular eFAST Phantom Advances AI Ultrasound Triage

Key Insights on Retinoblastoma and CSF Metastasis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.